(Q35803926)

10 August 2017

0 references

Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis (English)

1 reference

10 August 2017

1 reference

1 reference

1 reference

1 reference

R-H Tian

1

1 reference

10 August 2017

Y-G Zhang

2

1 reference

10 August 2017

Z Wu

3

1 reference

10 August 2017

X Liu

4

1 reference

10 August 2017

J-W Yang

5

1 reference

10 August 2017

H-L Ji

6

1 reference

10 August 2017

12 October 2015

1 reference

Clinical and Translational Oncology

10 August 2017

1 reference

10 August 2017

18

1 reference

10 August 2017

6

1 reference

10 August 2017

641-649

1 reference

https://scigraph.springernature.com/pub.10.1007/s12094-015-1412-x

10 August 2017

0 references

cites work

Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Nut consumption and risk of cancer and type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Global cancer statistics, 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Metformin and neoplasia: implications and indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

The use of metformin and the incidence of lung cancer in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Metformin: multi-faceted protection against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

The effect of metformin and thiazolidinedione use on lung cancer in diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Metformin does not alter the risk of lung cancer: a case-control analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Survival of patients with stage IV lung cancer with diabetes treated with metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Meta-analysis, funnel plots and sensitivity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Diabetes, insulin use, and cancer risk: are observational studies part of the solution-or part of the problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Immune-mediated antitumor effect by type 2 diabetes drug, metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1412-X

Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain

21 January 2018

1 reference

12 December 2020

Impact of metformin use on survival in locally-advanced, inoperable non-small cell lung cancer treated with definitive chemoradiation

1 reference

12 December 2020

Prognosis of small cell lung cancer patients with diabetes treated with metformin

1 reference

12 December 2020

Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers

1 reference

12 December 2020

The complexities of obesity and diabetes with the development and progression of pancreatic cancer

1 reference

12 December 2020

Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality

1 reference

12 December 2020

Metformin use improves the survival of diabetic combined small-cell lung cancer patients

1 reference

12 December 2020

10.1007/S12094-015-1412-X

Identifiers

DOI

1 reference

10 August 2017

1 reference